Company

Degron Therapeutics

Biotechnology Research San Diego, Ca, United States 16 employees

Employees: 16
Contacts: 4
Emails: 4
Phones: 1

www.degrontx.com LinkedIn

Degron Therapeutics Overview

Headquarters: San Diego, Ca, United States
Website: www.degrontx.com
Industry: Biotechnology Research
Employees: 16
Founded: 2021
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

molecular glue degrader drugs Oncology Inflammation Metabolic

About Degron Therapeutics

Degron Therapeutics aims to become a global leader in the discovery and development of a new class of targeted protein degradation therapeutics, small molecule molecular glue degrader (MGD) drugs. Degron has assembled a team of world-class executives and scientific leaders, bringing its scientific excellence to the identification and validation of disease targets, particularly those undruggable by conventional small molecule inhibitors, and novel selective MGD compounds to meet unmet medical needs in all therapeutic areas.

Degron Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 1; 25.0% coverage

Degron Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
I-Chung Lo	Drug Discovery - Certified Data Analyst	San Diego County, California, United States	Email
Siwei Li	Director of Dmpk at Degron Therapeutics	San Francisco Bay Area, United States	Email Phone
Julia Dou	Director - Drug Discovery - Structural	Shanghai, China	Email
Hai Ming Tang	Senior Director at Degron Therapeutics	United States	Email